IBI: AN928; Đorđe Medarević***, viši naučni saradnik, Univerzitet u Beogradu, Farmaceutski fakultet; Polje: tehničko tehnološke i biotehničke nauke; Period: 2020-2024;
eNauka profil: rp06397; ORCID: 0000-0003-4516-2575;
WOS indikatori: NR = 47; TC = 1116; HIndex = 22;
eNauka WOS indikatori: NR = 46; TC = 1021; HIndex = 21 ;
Lista A broj bodova: 224.0013 (346) 3.8%; Lista B broj bodova: 897.175 (346) 1.4%; Lista C broj bodova: 0.000 (0) nan%; Lista A broj bodova kolaboracije: 0.000 (0) nan%; Lista B broj bodova kolaboracije: 0.000 (0) nan%;
Statistika svih rezultata
| Statistika | Ukupno | 2013-2024 | 2015-2024 | 2018-2024 | 2020-2024 |
|---|---|---|---|---|---|
| Broj rezultata | 47 | 40 | 38 | 31 | 21 |
| Broj citata | 1116 | 901 | |||
| Broj M bodova | 229.00 | 229 | 229.00 | 229 | |
| Normirani broj citata | 1108.42 | 897.17 | |||
| Normirani broj M bodova rezultata kategorije M21a++M21a+M21+M22+M23+M24 | 224.00 | 224.00 | 224.00 | 224.00 | |
| Normirani broj M bodova rezultata kategorije M11+M12+M13+M14+M41 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Normirani broj M bodova rezultata kategorije M11+M12+M13+M14+M41+M42 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Normirani broj M bodova rezultata kategorije M51 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Normirani broj M bodova rezultata kategorije M43+M44 | 0.00 | 0.00 | 0.00 | 0.00 |
Statistika rezultata nastalih u medunarodnim kolaboracijama
| Statistika | Ukupno | 2013-2024 | 2015-2024 | 2018-2024 | 2020-2024 |
|---|---|---|---|---|---|
| Broj rezultata sa 20 i više autora | 0 | 0 | 0 | 0 | 0 |
| Broj citata rezultata sa 20 i više autora | 0 | 0 | |||
| Broj M bodova rezultata M21a++M21a+M21+M22+M23 sa 20 i više autora | 0.00 | 0 | 0.00 | 0 | |
| Normirani broj citata rezultata sa 20 i više autora | 0.00 | 0.00 | |||
| Normirani broj M bodova rezultata M21a++M21a+M21+M22+M23 sa 20 i više autora | 0.00 | 0.00 |
Rezultati
| RB | IBI | Godina | Kat | Tip | Vrsta | Referenca | TC | TCP | BA | NBB | NTC | Naslov | Autori | 1. | AN928 | 2012 | E | SCIENTIFIC WORLD JOURNAL Vol. (): #185085 - (10), (DOI: 10.1100/2012/185085) 2012WOS | 10 | 9 | 6 | 0 | 9.0000 | Design Space Approach in Optimization of Fluid Bed Granulation and Tablets Compression Process | Djuris J, Medarevic D, Krstic M, Vasiljevic I, Masic I, Ibric S | 2. | AN928 | 2013 | E | JOURNAL OF PHARMACEUTICAL SCIENCES Vol. 102 (6): # 1869 - 1882 (14), (DOI: 10.1002/jps.23530) JUN 2013WOS | 13 | 12 | 5 | 0 | 12.0000 | Application of quality by design concepts in the development of fluidized bed granulation and tableting processes | Djuris J, Medarevic D, Krstic M, Djuric Z, Ibric S | 3. | AN928 | 2014 | E | LATIN AMERICAN JOURNAL OF PHARMACY Vol. 33 (7): # 1131 - 1138 (8), (DOI: ) 2014WOS | 1 | 1 | 4 | 0 | 1.0000 | Establishing Design Space for Tramadol HCl Release from Hydrophilic Matrix Tablets | Nikolic N, Ibric S, Medarevic D, Djuric Z | 4. | AN928 | 2015 | E | EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES Vol. 78 (): # 273 - 285 (13), (DOI: 10.1016/j.ejps.2015.08.001) OCT 12 2015WOS | 55 | 52 | 4 | 0 | 52.0000 | Influence of hydrophilic polymers on the complexation of carbamazepine with hydroxypropyl-β-cyclodextrin | Medarevic D, Kachrimanis K, Djuric Z, Ibric S | 5. | AN928 | 2015 | E | CHEMICAL INDUSTRY & CHEMICAL ENGINEERING QUARTERLY Vol. 21 (3): # 369 - 378 (10), (DOI: 10.2298/CICEQ140613040N) JUL-SEP 2015WOS | 0 | 0 | 4 | 0 | 0.0000 | COMPARISON OF DRUG RELEASE AND MECHANICAL PROPERTIES OF TRAMADOL HYDROCHLORIDE MATRIX TABLETS PREPARED WITH SELECTED HYDROPHILIC POLYMERS | Nikolic N, Medarevic D, Duris J, Vasiljevic D | 6. | AN928 | 2015 | E | HEMIJSKA INDUSTRIJA Vol. 69 (5): # 503 - 510 (8), (DOI: 10.2298/HEMIND140317069N) SEP-OCT 2015WOS | 1 | 1 | 4 | 0 | 1.0000 | Evaluation of formulation and effects of process parameters on drug release and mechanical properties of tramadol hydrochloride sustained release matrix tablets | Nikolic N, Medarevic D, Ibric S, Djuric Z | 7. | AN928 | 2016 | E | HEMIJSKA INDUSTRIJA Vol. 70 (6): # 613 - 627 (15), (DOI: 10.2298/HEMIND150708069M) NOV-DEC 2016WOS | 28 | 27 | 3 | 0 | 27.0000 | Diatoms - nature materials with great potential for bioapplications | Medarevic D, Losic D, Ibric S | 8. | AN928 | 2016 | E | DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY Vol. 42 (3): # 389 - 402 (14), (DOI: 10.3109/03639045.2015.1054831) MAR 3 2016WOS | 29 | 24 | 5 | 0 | 24.0000 | Combined application of mixture experimental design and artificial neural networks in the solid dispersion development | Medarevic D, Kleinebudde P, Djuris J, Djuric Z, Ibric S | 9. | AN928 | 2016 | E | PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY Vol. 21 (3): # 268 - 276 (9), (DOI: 10.3109/10837450.2014.996899) APR 2 2016WOS | 49 | 41 | 6 | 0 | 41.0000 | Dissolution rate enhancement and physicochemical characterization of carbamazepine-poloxamer solid dispersions | Medarevic D, Kachrimanis K, Mitric M, Djuris J, Djuric Z, Ibric S | 10. | AN928 | 2017 | E | DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY Vol. 43 (5): # 723 - 731 (9), (DOI: 10.1080/03639045.2016.1220572) 2017WOS | 37 | 31 | 4 | 0 | 31.0000 | In vitro and in vivo investigation of taste-masking effectiveness of Eudragit E PO as drug particle coating agent in orally disintegrating tablets | Draskovic M, Medarevic D, Aleksic I, Parojcic J | 11. | AN928 | 2018 | E | LIPID NANOCARRIERS FOR DRUG TARGETING Vol. (): # 473 - 508 (36), (DOI: 10.1016/B978-0-12-813687-4.00012-8) 2018WOS | 98 | 74 | 4 | 0 | 74.0000 | Self-nanoemulsifying drug delivery systems (SNEDDS) and self-microemulsifying drug delivery systems (SMEDDS) as lipid nanocarriers for improving dissolution rate and bioavailability of poorly soluble drugs | Krstic M, Medarevic D, Duris J, Ibric S | 12. | AN928 | 2018 | E | EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES Vol. 124 (): # 188 - 198 (11), (DOI: 10.1016/j.ejps.2018.08.026) NOV 1 2018WOS | 25 | 23 | 6 | 0 | 23.0000 | Assessing the potential of solid dispersions to improve dissolution rate and bioavailability of valsartan: In vitro-in silico approach | Medarevic D, Cvijic S, Dobricic V, Mitric M, Djuris J, Ibric S | 13. | AN928 | 2018 | E | INTERNATIONAL JOURNAL OF PHARMACEUTICS Vol. 540 (1-2): # 150 - 161 (12), (DOI: 10.1016/j.ijpharm.2018.02.011) APR 5 2018WOS | 79 | 69 | 5 | 0 | 69.0000 | Optimization of formulation and process parameters for the production of carvedilol nanosuspension by wet media milling | Medarevic D, Djuris J, Ibric S, Mitric M, Kachrimanis K | 14. | AN928 | 2018 | E | SAUDI PHARMACEUTICAL JOURNAL Vol. 26 (5): # 725 - 732 (8), (DOI: 10.1016/j.jsps.2018.02.017) JUL 2018WOS | 30 | 28 | 7 | 0 | 28.0000 | Development of ternary solid dispersions with hydrophilic polymer and surface adsorbent for improving dissolution rate of carbamazepine | Vojinovic T, Medarevic D, Vranic E, Potpara Z, Krstic M, Djuris J, Ibric S | 15. | AN928 | 2019 | E | INTERNATIONAL JOURNAL OF PHARMACEUTICS Vol. 554 (): # 190 - 200 (11), (DOI: 10.1016/j.ijpharm.2018.11.015) JAN 10 2019WOS | 31 | 28 | 6 | 0 | 28.0000 | Selection of the suitable polymer for supercritical fluid assisted preparation of carvedilol solid dispersions | Djuris J, Milovanovic S, Medarevic D, Dobricic V, Dapcevic A, Ibric S | 16. | AN928 | 2019 | E | INTERNATIONAL JOURNAL OF PHARMACEUTICS Vol. 572 (): #118790 - (12), (DOI: 10.1016/j.ijpharm.2019.118790) DEC 15 2019WOS | 57 | 54 | 5 | 0 | 54.0000 | Hydrophilic excipients in digital light processing (DLP) printing of sustained release tablets: Impact on internal structure and drug dissolution rate | Krkobabic M, Medarevic D, Cvijic S, Grujic B, Ibric S | 17. | AN928 | 2019 | E | POLYMER TESTING Vol. 76 (): # 54 - 64 (11), (DOI: 10.1016/j.polymertesting.2019.03.001) JUL 2019WOS | 19 | 17 | 6 | 0 | 17.0000 | Soluplus®, Eudragit®, HPMC-AS foams and solid dispersions for enhancement of Carvedilol dissolution rate prepared by a supercritical CO2 process | Milovanovic S, Djuris J, Dapcevic A, Medarevic D, Ibric S, Zizovic I | 18. | AN928 | 2019 | E | JOURNAL OF PHARMACEUTICAL SCIENCES Vol. 108 (3): # 1326 - 1333 (8), (DOI: 10.1016/j.xphs.2018.10.054) MAR 2019WOS | 31 | 27 | 6 | 0 | 27.0000 | Comparison of the Effect of Bioadhesive Polymers on Stability and Drug Release Kinetics of Biocompatible Hydrogels for Topical Application of Ibuprofen | Djekic L, Martinovic M, Dobricic V, Calija B, Medarevic D, Primorac M | 19. | AN928 | 2019 | E | PHARMACEUTICS Vol. 11 (8): #372 - (33), (DOI: 10.3390/pharmaceutics11080372) AUG 2019WOS | 60 | 46 | 5 | 0 | 46.0000 | Analytical and Computational Methods for the Estimation of Drug-Polymer Solubility and Miscibility in Solid Dispersions Development | Medarevic D, Djuris J, Barmpalexis P, Kachrimanis K, Ibric S | 20. | AN928 | 2019 | E | PHARMACEUTICS Vol. 11 (10): #544 - (16), (DOI: 10.3390/pharmaceutics11100544) OCT 2019WOS | 53 | 44 | 7 | 0 | 44.0000 | Optimization and Prediction of Ibuprofen Release from 3D DLP Printlets Using Artificial Neural Networks | Madzarevic M, Medarevic D, Vulovic A, Sustersic T, Djuris J, Filipovic N, Ibric S | 21. | AN928 | 2020 | M21a | E | Article | INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES Vol. 148 (): # 942 - 955 (14), (DOI: 10.1016/j.ijbiomac.2020.01.138) APR 1 2020WOS | 52 | 46 | 6 | 12.0000 | 46.0000 | Study of chitosan/xanthan gum polyelectrolyte complexes formation, solid state and influence on ibuprofen release kinetics | Ciric A, Medarevic D, Calija B, Dobricic V, Mitric M, Djekic L | 22. | AN928 | 2020 | M21a | E | Article | JOURNAL OF MOLECULAR LIQUIDS Vol. 303 (): #112639 - (8), (DOI: 10.1016/j.molliq.2020.112639) APR 1 2020WOS | 34 | 26 | 3 | 12.0000 | 26.0000 | Gelation behavior, drug solubilization capacity and release kinetics of poloxamer 407 aqueous solutions: The combined effect of copolymer, cosolvent and hydrophobic drug | Djekic L, Calija B, Medarevic D | 23. | AN928 | 2020 | M21a | E | Article | PHARMACEUTICS Vol. 12 (1): #53 - (17), (DOI: 10.3390/pharmaceutics12010053) JAN 2020WOS | 22 | 16 | 6 | 12.0000 | 16.0000 | Insight into the Formation of Glimepiride Nanocrystals by Wet Media Milling | Medarevic D, Ibric S, Vardaka E, Mitric M, Nikolakakis I, Kachrimanis K | 24. | AN928 | 2020 | M21a | E | Article | PHARMACEUTICS Vol. 12 (9): #833 - (17), (DOI: 10.3390/pharmaceutics12090833) SEP 2020WOS | 41 | 33 | 6 | 12.0000 | 33.0000 | Digital Light Processing (DLP) 3D Printing of Atomoxetine Hydrochloride Tablets Using Photoreactive Suspensions | Krkobabiv M, Medarevic D, Pesic N, Vasiljevic D, Ivkovic B, Ibric S | 25. | AN928 | 2020 | M21 | E | Article | SAUDI PHARMACEUTICAL JOURNAL Vol. 28 (6): # 710 - 718 (9), (DOI: 10.1016/j.jsps.2020.04.013) JUN 2020WOS | 18 | 11 | 7 | 8.0000 | 11.0000 | Tableting properties of microcrystalline cellulose obtained from wheat straw measured with a single punch bench top tablet press | Krivokapic J, Ivanovic J, Djuris J, Medarevic D, Potpara Z, Maksimovic Z, Ibric S | 26. | AN928 | 2020 | M21 | E | Article | MINERALS Vol. 10 (1): #23 - (23), (DOI: 10.3390/min10010023) JAN 2020WOS | 19 | 18 | 7 | 8.0000 | 18.0000 | Flow and Tableting Behaviors of Some Egyptian Kaolin Powders as Potential Pharmaceutical Excipients | Awad M, López-Galindo A, Medarevic D, Duris J, El-Rahmany M, Ibric S, Viseras C | 27. | AN928 | 2021 | M21a | E | Article | INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES Vol. 167 (): # 547 - 558 (12), (DOI: 10.1016/j.ijbiomac.2020.11.201) JAN 15 2021WOS | 29 | 23 | 8 | 10.0000 | 19.1667 | Effect of ibuprofen entrapment procedure on physicochemical and controlled drug release performances of chitosan/xanthan gum polyelectrolyte complexes | Ciric A, Medarevic D, Calija B, Dobricic V, Rmandic M, Barudzija T, Malenovic A, Djekic L | 28. | AN928 | 2021 | M21a | E | Article | INTERNATIONAL JOURNAL OF PHARMACEUTICS Vol. 598 (): #120372 - (14), (DOI: 10.1016/j.ijpharm.2021.120372) APR 1 2021WOS | 14 | 12 | 7 | 12.0000 | 12.0000 | Enhanced antimicrobial activity and physicochemical stability of rapid pyro-fabricated silver-kaolinite nanocomposite | Awad M, López-Galindo A, Medarevic D, Milenkovic M, Ibric S, El-Rahmany M, Iborra C | 29. | AN928 | 2021 | M21a | E | Article | INTERNATIONAL JOURNAL OF PHARMACEUTICS Vol. 608 (): #121033 - (9), (DOI: 10.1016/j.ijpharm.2021.121033) OCT 25 2021WOS | 21 | 15 | 7 | 12.0000 | 15.0000 | Potential application of low molecular weight excipients for amorphization and dissolution enhancement of carvedilol | Pesic N, Dapcevic A, Ivkovic B, Kachrimanis K, Mitric M, Ibric S, Medarevic D | 30. | AN928 | 2021 | M21a | E | Article | PHARMACEUTICS Vol. 13 (11): #1969 - (21), (DOI: 10.3390/pharmaceutics13111969) NOV 2021WOS | 28 | 20 | 6 | 12.0000 | 20.0000 | Understanding the Effect of Energy Density and Formulation Factors on the Printability and Characteristics of SLS Irbesartan Tablets-Application of the Decision Tree Model | Madzarevic M, Medarevic D, Pavlovic S, Ivkovic B, Duris J, Ibric S | 31. | AN928 | 2021 | M21a | E | Article | PHARMACEUTICS Vol. 13 (12): #2165 - (13), (DOI: 10.3390/pharmaceutics13122165) DEC 2021WOS | 9 | 6 | 4 | 12.0000 | 6.0000 | Improving Tableting Performance of Lactose Monohydrate by Fluid-Bed Melt Granulation Co-Processing | Medarevic D, Djuris J, Krkobabic M, Ibric S | 32. | AN928 | 2021 | M21 | E | Article | JOURNAL OF POLYMER RESEARCH Vol. 28 (3): #74 - (12), (DOI: 10.1007/s10965-021-02440-1) FEB 3 2021WOS | 5 | 2 | 7 | 8.0000 | 2.0000 | Preparation of floating polymer-valsartan delivery systems using supercritical CO2 | Milovanovic S, Djuris J, Dapcevic A, Skoric M, Medarevic D, Pavlovic S, Ibric S | 33. | AN928 | 2021 | M21 | E | Article | MOLECULES Vol. 26 (1): #111 - (21), (DOI: 10.3390/molecules26010111) JAN 2021WOS | 42 | 33 | 6 | 8.0000 | 33.0000 | Tailoring Atomoxetine Release Rate from DLP 3D-Printed Tablets Using Artificial Neural Networks: Influence of Tablet Thickness and Drug Loading | Stanojevic G, Medarevic D, Adamov I, Pesic N, Kovacevic J, Ibric S | 34. | AN928 | 2022 | M21a+ | E | Article | INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES Vol. 221 (): # 48 - 60 (13), (DOI: 10.1016/j.ijbiomac.2022.08.190) NOV 30 2022WOS | 17 | 9 | 9 | 20.0000 | 9.0000 | Evaluation of chitosan/xanthan gum polyelectrolyte complexes potential for pH-dependent oral delivery of escin | Ciric A, Budincic J, Medarevic D, Dobricic V, Rmandic M, Barudzija T, Malenovic A, Petrovic L, Djekic L | 35. | AN928 | 2022 | M21a | E | Article | INTERNATIONAL JOURNAL OF PHARMACEUTICS Vol. 624 (): #122046 - (11), (DOI: 10.1016/j.ijpharm.2022.122046) AUG 25 2022WOS | 27 | 18 | 7 | 12.0000 | 18.0000 | Formulation and characterization of immediate-release oral dosage forms with zolpidem tartrate fabricated by digital light processing (DLP) 3D printing technique | Adamov I, Stanojevic G, Medarevic D, Ivkovic B, Kocovic D, Mirkovic D, Ibric S | 36. | AN928 | 2022 | M21 | E | Article | PLOS ONE Vol. 17 (4): #e0266237 - (14), (DOI: 10.1371/journal.pone.0266237) APR 4 2022WOS | 7 | 3 | 7 | 8.0000 | 3.0000 | Long-term stability of clopidogrel solid dispersions-Importance of in vitro dissolution test | Omerdic E, Alagic-Dzambic L, Krstic M, Pasic-Kulenovic M, Medarevic D, Ivkovic B, Vasiljevic D | 37. | AN928 | 2024 | M21a | E | Article | INTERNATIONAL JOURNAL OF PHARMACEUTICS Vol. 657 (): #124161 - (13), (DOI: 10.1016/j.ijpharm.2024.124161) MAY 25 2024WOS | 5 | 2 | 7 | 12.0000 | 2.0000 | Powder bed fusion -laser beam (PBF-LB) three-dimensional (3D) printing: Influence of laser hatching distance on the properties of zolpidem tartrate tablets | Adamov I, Stanojevic G, Pavlovic S, Medarevic D, Ivkovic B, Kocovic D, Ibric S | 38. | AN928 | 2024 | M21a | E | Article | PHARMACEUTICS Vol. 16 (8): #1090 - (17), (DOI: 10.3390/pharmaceutics16081090) AUG 2024WOS | 2 | 0 | 7 | 12.0000 | 0.0000 | From Field to Pharmacy: Isolation, Characterization and Tableting Behaviour of Microcrystalline Cellulose from Wheat and Corn Harvest Residues | Medarevic D, Cezek M, Knezevic A, Turkovic E, Barudzija T, Samardzic S, Maksimovic Z | 39. | AN928 | 2024 | M21a | E | Article | PHARMACEUTICS Vol. 16 (9): #1182 - (25), (DOI: 10.3390/pharmaceutics16091182) SEP 2024WOS | 5 | 0 | 6 | 12.0000 | 0.0000 | Extracts from Wheat, Maize, and Sunflower Waste as Natural Raw Materials for Cosmetics: Value-Added Products Reaching Sustainability Goals | Lukic M, Ciric A, Bozic D, Stankovic J, Medarevic D, Maksimovic Z | 40. | AN928 | 2024 | M21 | E | Article | MATERIALS CHEMISTRY AND PHYSICS Vol. 325 (): #129756 - (10), (DOI: 10.1016/j.matchemphys.2024.129756) OCT 1 2024WOS | 5 | 0 | 10 | 5.0000 | 0.0000 | Modification of selectively acid-etched halloysite by mucoadhesive chitosan derivatives: New bionanocomposites with improved functional properties | Jaukovic V, Calija B, Ivkovic B, Khutoryanskiy V, Abu E, Kurcubic I, Medarevic D, Stojanovic J, Damjanovic A, Krajisnik D | 41. | AN928 | 2024 | M22 | E | Review | FARMACIA Vol. 72 (6): # 1251 - 1260 (10), (DOI: 10.31925/farmacia.2024.6.3) NOV-DEC 2024WOS | 0 | 0 | 4 | 5.0000 | 0.0000 | THE ROLE OF 3D PRINTING IN THE DEVELOPMENT OF DOSAGE FORMS WITH TAILORED DRUG RELEASE | Potpara Z, Medarevic D, Krstic M, Ibric S | 42. | AN928 | 2025 | E | CELLULOSE Vol. 32 (13): # 7783 - 7802 (20), (DOI: 10.1007/s10570-025-06687-5) SEP 2025WOS | 0 | 0 | 6 | 0 | 0.0000 | Development of co-processed excipient from wheat harvest residue-derived microcrystalline cellulose suitable for formulation of immediate release tablets containing high-dose drug | Medarevic D, Cezek M, Djuris M, Markovic B, Djuris J, Maksimovic Z | 43. | AN928 | 2025 | E | INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES Vol. 306 (): #141514 - (14), (DOI: 10.1016/j.ijbiomac.2025.141514) MAY 2025WOS | 3 | 0 | 8 | 0 | 0.0000 | Pectin as the carrier for the spray drying of green tea extracts: Tailoring microencapsulation to obtain a prospective nutraceutical | Zugic A, Krgovic N, Mudric J, Kostov M, Tomovic M, Medarevic D, Nesic I, Tadic V | 44. | AN928 | 2025 | E | PHARMACEUTICALS Vol. 18 (10): #1504 - (29), (DOI: 10.3390/ph18101504) OCT 7 2025WOS | 0 | 0 | 7 | 0 | 0.0000 | Development and Evaluation of 3D-Printed Losartan Potassium Tablets Using Semi-Solid Extrusion: The Effect of Geometry, Drug Loading and Superdisintegrant | Vojinovic A, Medarevic D, Stanojevic G, Mirkovic D, Mugosa S, Adamov I, Ibric S | 45. | AN928 | 2025 | E | PHARMACEUTICS Vol. 17 (1): #6 - (17), (DOI: 10.3390/pharmaceutics17010006) JAN 2025WOS | 4 | 0 | 6 | 0 | 0.0000 | Selective Laser Sintering 3D Printing of Carvedilol Tablets: Enhancing Dissolution Through Amorphization | Pesic N, Ivkovic B, Barudzija T, Grujic B, Ibric S, Medarevic D | 46. | AN928 | 2025 | E | PHARMACEUTICS Vol. 17 (1): #71 - (28), (DOI: 10.3390/pharmaceutics17010071) JAN 2025WOS | 1 | 0 | 10 | 0 | 0.0000 | Dual-Mechanism Gastroretentive Tablets with Encapsulated Gentian Root Extract | Mudric J, Dekic L, Krgovic N, Medarevic D, Savikin K, Radan M, Nikolic N, Ilic T, Vidovic B, Duris J | 47. | AN928 | 2025 | E | PLANTS-BASEL Vol. 14 (3): #346 - (20), (DOI: 10.3390/plants14030346) FEB 2025WOS | 0 | 0 | 6 | 0 | 0.0000 | Antioxidant, Enzyme-Inhibitory and Antimicrobial Activity of Underutilized Wheat and Maize Crop Residues | Samardzic S, Velickovic I, Milenkovic M, Arsenijevic J, Medarevic D, Maksimovic Z |
|---|
27. 04. 2026.; 00:10:28; Trajanje procesiranja: 0.024 s
Legenda:
RB - redni broj rezultata
IBI - identifikacioni broj istraživača
Godina - godina u kojoj je rezultat publikovan (isključivo sa kompletnom paginacijom)
Kat - kategorija rezulata
Tip - tip rezultata (teorijski, simulacioni ili eksperimentalni)
Vrsta - vrsta rezultata
Referenca - referenca rezultata (bez autora i naslova rezultata) sa direktnim linkom na rezultat (ako ima DOI broj), sa linkom na zapis u eNauci ili WOS
TC - ukupan broj citata rezulata na dan 31. 1. 2026. godine
TCP - ukupan broj citata rezultata u periodu 2015-2024
BA - broj autora na rezultatu
NBB - normirani broj bodova rezultata
NTC - normirani broj citata rezultata u periodu 2015-2024
Naslov - naslov rezultata
Autori - spisak svih autora ili najviše prvih 30 autora
Primer:
Primer normiranja broja M poena i broja citata ostvarenih na jednom rezultatu: eksperimentalni rad sa 11 autora u časopisu kategorije M21a+ koji je publikovan 2020. godine, citiran je 65 puta, od čega 55 puta u periodu 2015-2024. godine.
Normirani broj M poena koje istraživač ostvaruje na rezultatu je 20/(1+0.2*(11-10))=16.6667 a normirani broj citata je 55/(1+0.2*(11-10))=45.8333.
Ukupan broj ostaverinih bodova utvrđuje se na naznačenom periodu za sabiranje normiranih M poena svakog istraživača i u periodu za određivanje ukupnog broja normiranih citata (2015-2024).